Influenza Hemagglutinin (HA) Peptide: Precision Tag for Advanced Protein Purification

Principle and Setup: The Role of the HA Tag Peptide in Molecular Biology

The Influenza Hemagglutinin (HA) Peptide (SKU: A6004) has established itself as a cornerstone reagent in molecular biology, cell biology, and protein biochemistry. This synthetic nine-amino acid epitope tag (sequence: YPYDVPDYA) is derived from the influenza hemagglutinin protein, serving as a universal molecular tag for fusion protein detection, purification, and elution. Its high solubility (≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, and ≥46.2 mg/mL in water) and exceptional purity (>98%, validated by HPLC and mass spectrometry) make it ideally suited for complex experimental environments.

The HA tag peptide’s core function is its ability to mediate competitive binding to Anti-HA antibody, enabling precise elution of HA-tagged fusion proteins from immunoprecipitation matrices. This capability is pivotal for workflows such as immunoprecipitation with Anti-HA antibody, pull-down assays, protein–protein interaction studies, and high-throughput proteomics. Its short, well-characterized HA tag sequence and compatibility with a wide range of expression systems further reinforce its status as a gold standard epitope tag for protein detection and protein purification tag.

Experimental Workflow: Leveraging the HA Peptide for High-Efficiency Protein Purification

1. Construct Design and Expression

• Clone the gene of interest in-frame with the hemagglutinin tag using the established ha tag dna sequence or ha tag nucleotide sequence (5′-TACCCATACGACGTCCCAGACTACGCT-3′), ensuring correct orientation and reading frame.
• Express the HA-tagged fusion protein in the desired system (e.g., mammalian, yeast, or bacterial cells).

2. Cell Lysis and Sample Preparation

• Harvest cells and lyse under conditions compatible with protein stability and downstream analysis.
• Clarify lysate by centrifugation. Use recommended buffers (containing protease inhibitors) to minimize degradation.

3. Immunoprecipitation with Anti-HA Antibody

• Incubate clarified lysate with Anti-HA magnetic beads or resin-bound antibody to capture HA-tagged proteins via the influenza hemagglutinin epitope.
• Wash beads thoroughly to remove non-specifically bound proteins.

4. HA Fusion Protein Elution Using HA Peptide

• Prepare a fresh solution of the ha peptide in an appropriate buffer (e.g., PBS or Tris-HCl, pH 7.4) ensuring a final concentration between 0.5–2 mg/mL for efficient elution. Use solubility guidelines based on your buffer system.
• Add peptide solution to the beads and incubate at 4°C with gentle agitation for 30–60 minutes. The competitive binding to Anti-HA antibody displaces the HA-tagged fusion protein.
• Collect the eluate by centrifugation or magnetic separation. Analyze by SDS-PAGE, Western blotting, or further downstream applications.

Tip: For maximum yield and purity, optimize peptide concentration and incubation time based on the specific antibody and fusion construct used.

Performance Benchmark

Peer-reviewed studies and product validation data consistently report elution efficiencies exceeding 90% under optimized conditions, with negligible contamination from non-target proteins. For example, as highlighted in "Benchmark Epitope Tag Peptide", the A6004 HA tag peptide enables clean, quantitative recovery of HA-tagged proteins in both standard and high-stringency buffer environments—an advantage over larger or less soluble tags.

Advanced Applications and Comparative Advantages

Protein–Protein Interaction Studies and Mechanistic Insights

The HA tag peptide's small size and low immunogenicity minimize steric interference, making it ideal for sensitive protein–protein interaction studies. Recent research, such as the RAB31-mediated exosome biogenesis study (Wei et al., 2021), leveraged HA-tagged constructs to dissect vesicular trafficking pathways. The use of competitive HA peptide elution ensured that transient, physiologically relevant complexes were recovered without harsh denaturation, allowing downstream mass spectrometry and functional assays.

Quantitative Protein Purification in Translational and Cancer Research

In "Next-Generation Strategies for Mechanistic Cancer Research", the HA tag peptide was instrumental for isolating low-abundance signaling proteins in tumor lysates, where conventional tags failed due to background binding or poor solubility. Its robust performance in high-throughput or automated platforms underscores its utility for quantitative proteomics and biomarker discovery.

Extending Beyond Standard Protocols

As reviewed in "Precision Tag for Protein–Protein Interaction Studies", the HA peptide is compatible with multiplex detection strategies, enabling simultaneous analysis of multiple tagged constructs in complex biological samples. This capability is particularly valuable in systems biology, interactomics, and clinical translational workflows.

Troubleshooting and Optimization Tips

• Low Elution Efficiency: Increase the concentration of HA peptide incrementally (up to 2–5 mg/mL), extend incubation time, or reduce elution temperature to enhance competitive displacement.
• Non-Specific Binding: Implement stringent wash steps (high-salt or detergent-containing buffers) prior to elution. Verify antibody specificity and bead quality.
• Tag Accessibility Issues: Ensure the HA tag is exposed in the fusion protein by validating construct design with structural prediction tools. N- or C-terminal positioning may influence accessibility.
• Peptide Stability: Store lyophilized peptide desiccated at -20°C. Prepare fresh working solutions for each experiment, as long-term storage of peptide solutions may lead to degradation.
• Buffer Compatibility: Exploit the peptide’s high solubility profile to tailor elution buffers for sensitive downstream applications (e.g., mass spectrometry, enzyme assays).

For more troubleshooting insights and comparative data, see "Gold Standard Molecular Biology Tag", which details optimization strategies for immunoprecipitation and elution specificity in complex lysates.

Future Outlook: Evolving Epitope Tag Technologies and the Role of the HA Peptide

The landscape of molecular biology and proteomics is rapidly advancing toward higher sensitivity, multiplexing, and functional characterization of protein networks. The Influenza Hemagglutinin (HA) Peptide continues to set benchmarks for reliability, versatility, and reproducibility in these workflows. Its compatibility with CRISPR/Cas-mediated genome editing, single-cell proteomics, and in vivo protein tracking positions it as a foundational tool for next-generation research.

Emerging trends, such as the integration of HA tag systems with microfluidic platforms and high-resolution imaging, are expected to further expand its utility. According to "Unleashing Precision in Translational Research", the strategic deployment of the HA tag peptide is central to enhancing assay reproducibility and bridging discovery with clinical applications.

As research demands grow more complex, trusted suppliers like APExBIO provide the validated, high-purity reagents needed to drive innovation and ensure experimental success.

Conclusion

The Influenza Hemagglutinin (HA) Peptide stands as a precision-engineered molecular biology peptide tag, offering unmatched performance for detection, purification, and mechanistic studies of HA-tagged proteins. By integrating this gold-standard HA tag peptide into your workflows, you unlock advanced capabilities in protein–protein interaction analysis, immunoprecipitation, and translational research—supported by a robust foundation of peer-reviewed evidence and best-in-class supplier quality.